Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 2 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 7 most recent Form 4 transactions.
| Jul 1, 2025 | INZY | Inozyme Pharma, Inc. | UTENDR | 423,926 | $4.00 | $1.7M | -100.0% | Open the original filing on SEC.gov |
| May 15, 2025 | INZY | Inozyme Pharma, Inc. | MEXER◆ | 4,407 | — | — | — | Open the original filing on SEC.gov |
| May 15, 2025 | INZY | Inozyme Pharma, Inc. | MEXER◆ | 152,823 | — | — | — | Open the original filing on SEC.gov |
| May 15, 2025 | INZY | Inozyme Pharma, Inc. | MEXER | 4,407 | $0.98 | $4.3K | +1.1% | Open the original filing on SEC.gov |
| May 15, 2025 | INZY | Inozyme Pharma, Inc. | MEXER | 152,823 | $0.98 | $149.8K | +57.3% | Open the original filing on SEC.gov |